These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 2620657)

  • 21. Nuclear triiodothyronine receptor binding characteristics and occupancy in obese (ob/ob) mice.
    Hillgartner FB; Romsos DR
    Am J Physiol; 1987 Mar; 252(3 Pt 1):E414-9. PubMed ID: 3826366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of selenite and selenate on rat liver nuclear 3,5,3'-triiodothyronine (T3) receptor.
    Brtko J; Filipcík P
    Biol Trace Elem Res; 1994; 41(1-2):191-9. PubMed ID: 7946906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of nuclear T3 binding by fatty acids.
    Wiersinga WM; Chopra IJ; Teco GN
    Metabolism; 1988 Oct; 37(10):996-1002. PubMed ID: 3173114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in nuclear thyroid hormone receptors among species.
    Ichikawa K; Hashizume K; Miyamoto T; Sakurai A; Yamauchi K; Nishii Y; Yamada T
    Gen Comp Endocrinol; 1989 Apr; 74(1):68-76. PubMed ID: 2500375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of 3,5,3'-triiodothyronine binding to its receptor in rat liver by protease inhibitors and substrates.
    Brtko J; Knopp J; Baker ME
    Mol Cell Endocrinol; 1993 May; 93(1):81-6. PubMed ID: 8319835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thioredoxin and glutaredoxin enhance the binding of L-triiodothyronine to its hepatic nuclear receptors.
    Takagi S; Bhat GB; Hummel BC; Walfish PG
    Biochem Cell Biol; 1989 Aug; 67(8):477-80. PubMed ID: 2590531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin A deficiency and tri-iodothyronine action at the cellular level in the rat.
    Higueret P; Pailler I; Garcin H
    J Endocrinol; 1989 Apr; 121(1):75-9. PubMed ID: 2715762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heterogeneous distribution of nuclear triiodothyronine receptors in liver and preadipose cells as evidenced by their reactivity to antibodies against different protein products of erb A oncogenes.
    Torresani J; Ghysdael J; Bismuth J; Teboul M; Ghiringhelli O; Savary J
    FEBS Lett; 1989 Jul; 250(2):251-6. PubMed ID: 2546798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Modulation of the binding characteristics of thyroid hormone receptors by the chemical modification of non-histone nuclear proteins].
    Brtko J; Knopp J
    Bratisl Lek Listy; 1990 Mar; 91(3):167-71. PubMed ID: 2340415
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in glutathione status and 3,5,3'-triiodothyronine action in livers of rats given cysteine-deficient diets.
    Garcin H; Suberville C; Higueret P; Higueret D
    Br J Nutr; 1989 Mar; 61(2):301-7. PubMed ID: 2706229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. c-erb-A mRNA content and triiodothyronine nuclear receptor binding capacity in rat liver according to vitamin A status.
    Pailler-Rodde I; Garcin H; Higueret P; Begueret J
    FEBS Lett; 1991 Sep; 289(1):33-6. PubMed ID: 1654276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triiodothyronine binding sites in the rat erythrocyte membrane: involvement in triiodothyronine transport and relation to the tryptophan transport System T.
    Samson M; Osty J; Francon J; Blondeau JP
    Biochim Biophys Acta; 1992 Jul; 1108(1):91-8. PubMed ID: 1643084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thyroid hormone responsiveness of the L1210 murine leukemia cell line.
    Brtko J; Filipcík P; Knopp J; Sedláková V; Rauová L
    Acta Endocrinol (Copenh); 1992 Apr; 126(4):374-7. PubMed ID: 1595331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental values of the ionization constants for L-3,5-di-iodotyrosine and a model for ionic interactions of thyroid hormone (T3) and its nuclear receptor.
    Gent WL; Wilson BD
    Biochem Pharmacol; 1989 Jan; 38(2):343-6. PubMed ID: 2914019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conformational transition of thyroid hormone receptor upon hormone binding: demonstration by aqueous two-phase partitioning.
    Ichikawa K; Hashizume K; Miyamoto T; Nishii Y; Yamauchi K; Ohtsuka H; Yamada T
    J Endocrinol; 1988 Dec; 119(3):431-7. PubMed ID: 2464661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunocytochemical localization of the nuclear 3,5,3'-triiodothyronine receptor in the adult rat: liver, kidney, heart, lung and spleen.
    Luo M; Faure R; Tong YA; Dussault JH
    Acta Endocrinol (Copenh); 1989 Apr; 120(4):451-8. PubMed ID: 2655363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibody against nuclear thyroid hormone receptors.
    Ichikawa K; DeGroot LJ
    Biochem Biophys Res Commun; 1987 Apr; 144(1):178-84. PubMed ID: 2437906
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An assay procedure for solubilized thyroid hormone receptor: use of Lipidex.
    Li Q; Yamamoto N; Inoue A; Morisawa S
    Anal Biochem; 1991 Jan; 192(1):138-41. PubMed ID: 2048715
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical modification of critical catalytic residues of lysine, arginine, and tryptophan in human glucose phosphate isomerase.
    Lu HS; Talent JM; Gracy RW
    J Biol Chem; 1981 Jan; 256(2):785-92. PubMed ID: 6778875
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 1,2-Cyclohexanedione modification of arginine residues in egg-white riboflavin-binding protein.
    Kozik A; Guevara I; Zak Z
    Int J Biochem; 1988; 20(7):707-11. PubMed ID: 3181600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.